Project Grant HT9425261E053
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Federal Grant Award Summary New York University School of Medicine has received a $2.54 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2028. The award supports research and development activities focused on advancing a novel therapeutic strategy for amyotrophic lateral sclerosis (ALS) treatment through investigation of the RAGE/DIAPH1 axis. As a premier academic medical...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration received a $999,999 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2029. This award supports biomarker discovery research utilizing a Schwann cell-derived extracellular vesicle platform to identify and develop biomarkers for amyotrophic lateral sclerosis (ALS) in biofluids. The research...
- Federal Grant Award Summary New York University School of Medicine received a $1.67M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research identifying pathways that prevent the emergence of drug-tolerant persisters. The award, made on September 30, 2026, with an ultimate completion date of September 29, 2029, supports basic and applied biomedical research designed to develop innovative medical solutions...
- Federal Grant Award Summary New York University School of Medicine received a $833,334 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2026, through September 29, 2029. The award supports research directed at "Identifying Pathways That Prevent the Emergence of Drug-Tolerant Persisters," a three-year basic and applied biomedical research initiative designed to advance innovative medical...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the Weizmann Institute of Science a $939,325 project grant effective November 1, 2025, through October 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). This award supports GLOBALS (Global Omic Biomarker Research for ALS), a research initiative focused on identifying and validating omic biomarkers for amyotrophic lateral sclerosis (ALS). The project delivers advanced biomarker discovery...
- Federal Grant Award Summary New York University School of Medicine received a $2.01M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research titled "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation," conducted at NYU's location in New York, New York. This research investigates the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Barrow Neurological Institute at St. Joseph's Hospital and Medical Center $840,000 through the Military Medical Research and Development program (CFDA 12.420) for the project "Targeting M6A Dysregulation in ALS via Small Molecule Approaches." The award, effective July 1, 2026 through June 30, 2028, funds hypothesis-driven biomedical research aimed at developing therapeutic solutions for amyotrophic lateral sclerosis...
- Federal Grant Award Summary The University of Massachusetts Medical School (UMMS) received a $836,992 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to investigate the effects of military-associated environmental toxins on motor neurons and glial cells in sporadic amyotrophic lateral sclerosis (ALS). The award, effective August 1, 2025, through July 31, 2028, supports hypothesis-driven biomedical research...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded April 1, 2026, with a completion date of March 31, 2028. The award supports research efforts titled "Repurposing Approved Drugs as First-in-Class Disruptors of the P38/MK2 Complex to Suppress Neuroinflammation in ALS," with research activities...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.344 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2029. The award supports research on targeting noncanonical Wnt signaling to prevent Ewing sarcoma metastases utilizing a novel zebrafish model. This research addresses a critical cancer biology challenge relevant to military medical...